Learn everything you need to know about successful options trading with this three-part video course.Looking for new stock ideas? Get short term trading ideas from the MarketBeat Idea Engine. Asymptomatic children who contract COVID-19 may ‘shed’ coronavirus for weeks Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Get daily stock ideas top-performing Wall Street analysts. The dark blue line represents the company's actual earnings per share. Return On Capital Employed Overview: TherapeuticsMD.
© American Consumer News, LLC dba MarketBeat® 2010-2020. The reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.02. TherapeuticsMD Inc. analyst estimates by MarketWatch. Learn everything you need to know about successful options trading with this three-part video course.Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:You have already added five stocks to your watchlist. Log in to see them here or sign up to get started.Create a list of the investments you want to track.Visit a quote page and your recently viewed tickers will be displayed here.TherapeuticsMD nabs new U.S. patents covering contraceptive AnnoveraTherapeuticsMD: Remaining Bullish On This Reopening Play In The Biotech SectorTherapeuticsMD/Knight Therapeutics' Imvexxy OK'd in CanadaTherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q2 2020 Results - Earnings Call TranscriptIn a report released today, Douglas Tsao from H.C.[...]TherapeuticsMD, Inc. 2020 Q2 - Results - Earnings Call PresentationTherapeuticsMD (TXMD) delivered earnings and revenue surprises of -13.33% and -10.30%, respectively, for the quarter ended June 2020. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Learn about financial terms, types of investments, trading strategies and more.MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Get prepared with the key expectations.TherapeuticsMD (TXMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Please log in to your account or sign up in order to add this asset to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL. Read or listen to the conference call. TherapeuticsMD, Inc. is a pharmaceutical company, which focuses on developing and commercializing products for women.
The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. TherapeuticsMD (NASDAQ: TXMD) reported Q2 sales of $10.70 million. TherapeuticsMD last announced its quarterly earnings results on August 6th, 2020.
Do the numbers hold clues to what lies ahead for the stock?TherapeuticsMD (TXMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Therapeuticsmd (TXMD) reports earnings on 11/5/2020. See what's happening in the market right now with MarketBeat's real-time news feed. View our full suite of financial calendars and market data tables, all for free.Receive a free world-class investing education from MarketBeat. Nasdaq Composite climbs 1.2% Get prepared with the key expectations.In a report issued on July 15, Ahu Demir from Noble Financial maintained a Buy rating on TherapeuticsMD (TXMD), with a price target ...[...]TherapeuticsMD Announces Participation at Two Upcoming Virtual Investor ConferencesTherapeuticsMD Announces Patent Updates for ANNOVERA®Focusing on the Most Popular Robinhood Stocks: $TSLA $TXMD $TLRYGlobal Estrogen Replacement Therapy Market 2020 Key Players, Regions, Company Profile, Growth Opportunity and Challenges by 2025Global Estrogen Replacement Therapy Market 2020 Industry Size, Share, In-Depth Qualitative Insights, Growth Opportunity, Regional Analysis by 2025Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY(R)Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY®Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY(R)Bullish US Stock Most Popular On Robinhood: $NYMT $TXMD $PSECBioidentical Hormones Market: 2020 Global Trend, Size, Shares, Revenue, Growth Rate, Outlook, Overview, SWOT Analysis, Future Scope and Forecast to 2026Bioidentical Hormones Market: 2020 Global Trend, Size, Shares, Revenue, Growth Rate, Outlook, Overview, SWOT Analysis, Future Scope and Forecast to 2026Women's Health Market Share, Growth Analysis, Global Trends, Industry Overview, Regional Forecast by 2026 | Top Leaders Eli Lilly and Company; Novartis AG; Pfizer Inc.; Merck & Co., Inc.; Novo Nordisk A/S; Amgen Inc.; Lupin Pharmaceuticals, Inc.TherapeuticsMD® Announces Second Quarter 2020 Financial ResultsWomen's Healthcare Market assessed at USD 9.6 billion in 2019 is expected to reach USD 23.8 billion by 2026, at a CAGR of 13.2 % during the forecast periodGlobal Estrogen Replacement Therapy Market 2020 Industry Analysis, Key Drivers, Business Strategy, Opportunities and Forecast to 2025TherapeuticsMD to Report Second Quarter 2020 Results on August 6, 2020Vasomotor Symptoms of Menopause Treatment Market Share, Size Global Growth Prospects, Trends, Industry Analysis, Impact of Covid-19 on Industry,Key Players and Forecast to 2025Bioidentical Hormones Market Size, Future Forecasts, Growth rate, and Industry Analysis To 2029 | Advantage Pharmaceuticals Inc., TherapeuticsMD Inc., Biostation, BioTE MedicalGlobal Vasomotor Symptoms of Menopause Treatment Market 2020 Research Report With COVID-19 Update - Key Players Analysis, Growth Factors and Forecast to 2025Global Menopausal Disorder Treatment Market Size, Share, Trends, Business Strategy To 2027|Leading with Top Key Players like Aurobindo Pharma., Teva Pharmaceutical Industries Ltd., Prinston Pharmaceutical Inc., TherapeuticsMD, Inc